Professional Documents
Culture Documents
Fact Sheet 47
Fact Sheet 47
Fragile X Syndrome©2006
What is Fragile X Syndrome?
Fragile X syndrome (FXS) is the most common inherited form of mental retardation, affecting
approximately 1 in 4000 males and 1 in 8000 females. Males typically present with developmental
and language delays, behavioral and emotional problems, hyperactivity, autistic-like behavior and
moderate to severe mental retardation (IQ of 30-50). Physical characteristics include a long face,
large ears, a prominent jaw, and enlarged testicles. Often these physical features become more
apparent during puberty. Females typically present with a milder presentation because of the X-
linked nature of the mutation. Males have one X chromosome and one Y chromosome, whereas
females have two X chromosomes. Features in females include learning disabilities typically
involving math, attention difficulties, emotional problems (anxiety, depression, &/or shyness), and
poor social skills. Individuals with fragile X syndrome typically have minimal serious medical issues
and generally live a normal lifespan. There is currently no cure or specific treatment available for
FXS; however, therapy is available to help maximize an individual’s potential. In addition, ongoing
research at Emory University is focused on understanding the mutation to help develop possible
treatment approaches.
The FMR1 gene exists in three different forms: normal, premutation and full mutation. The three
forms differ based on the length of a DNA sequence that is repeated (CGG repeat), similar to a
genetic “stutter,” in which a small section of the genetic material within the gene is repeated too
many times. The FMR1 gene is responsible for making the FMR protein, which functions in
communication between nerve cells in the brain.
Individuals in the normal range have 6-50 copies of the CGG repeat, with the average being around
30. The number of CGG repeats varies from individual to individual. When in the repeat of 6-50
range, the repeat number is usually passed from parent to child in a stable manner. For example, if
a father has 30 copies of the CGG repeat, then his daughter will also have 30 CGG repeats.
Individuals who have between 55 and 200 repeats do not express fragile X-associated symptoms
and are referred to as premutation carriers; however, premutation carriers are at increased risk for
other disorders, such as premature ovarian failure and fragile X associated tremor ataxia syndrome
(see below for additional information). Approximately 1 in 250 women and 1 in 800 men are carriers
of the premutation form of the gene. The fragile X mutation is inherited in an X-linked pattern,
although it is more complicated because of the unstable repeat sequence. The premutation is not
transmitted in a stable manner from parent to child and the number of repeats could expand or
increase in each generation. For men who carry the premutation, ALL of his daughters will be fragile
X mutation carriers. Almost always, the daughters will carry the premutation form of the gene. These
daughters will have up to a 50% chance of having a child with FXS. Sons of men with the
premutation will NOT inherit the mutation and will NOT be carriers. For women who carry the
premutation, their sons and daughters have up to a 50% chance of carrying the fragile X mutation.
The chance that the premutation expands to the full mutation and leads to FXS depends on the
repeat size carried by the mother.
Finally, when the number of CGG repeats exceeds 200, a chemical change occurs in the cells
(methylation), which turns off the FMR1 gene. If the gene is turned off, the protein cannot be made.
This form of the gene is called the full mutation because it causes the symptoms of fragile X
syndrome (FXS). Approximately 1/3-1/2 of females with the full mutation shows clinical symptoms of
fragile X syndrome.
Resources
• The National Fragile X Foundation: The NFXF provides patient friendly information on their website at
www.fragilex.org or by calling (800) 688-8765.
• The Fragile X Association of Georgia: This parent led association can provide information, support,
and guidance for newly diagnosed families in Georgia. For more information e-mail parent sources at
frax@bellsouth.net
• FRAXA – The Fragile X Research Foundation: Their mission is to find effective treatments and a cure
for all children and adults with Fragile X. To obtain additional information, visit their website at
www.fraxa.org.